Prialt
E559468
Prialt is a non-opioid prescription pain medication (ziconotide) used for severe chronic pain, administered intrathecally and originally developed by Elan Pharmaceuticals.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Prialt canonical | 1 |
Statements (30)
| Predicate | Object |
|---|---|
| instanceOf |
brand name drug
ⓘ
pharmaceutical drug ⓘ |
| administrationForm | solution for intrathecal infusion ⓘ |
| approvalYear | 2004 ⓘ |
| approvedBy | U.S. Food and Drug Administration NERFINISHED ⓘ |
| commonAdverseEffect |
confusion
ⓘ
dizziness ⓘ headache ⓘ nausea ⓘ nystagmus ⓘ |
| contraindicatedIn | patients with a history of psychosis ⓘ |
| derivedFrom |
cone snail venom peptide
ⓘ
ω-conotoxin MVIIA NERFINISHED ⓘ |
| developedBy | Elan Pharmaceuticals NERFINISHED ⓘ |
| hasActiveIngredient | ziconotide ⓘ |
| hasATCCode | N02BG08 ⓘ |
| hasDrugClass |
analgesic
ⓘ
non-opioid analgesic ⓘ |
| hasGenericName | ziconotide ⓘ |
| indicatedFor |
chronic pain in patients requiring intrathecal therapy
ⓘ
severe chronic pain ⓘ |
| isSynthetic | true ⓘ |
| marketedAs | Prialt NERFINISHED ⓘ |
| mechanismOfAction | N-type voltage-sensitive calcium channel blocker ⓘ |
| originSpecies | Conus magus ⓘ |
| requires | implantable intrathecal delivery system or external pump ⓘ |
| routeOfAdministration | intrathecal ⓘ |
| seriousAdverseEffect |
meningitis (related to intrathecal delivery system)
ⓘ
psychiatric symptoms ⓘ |
| target | N-type calcium channels in the dorsal horn of the spinal cord ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.